Takara Bio Inc.
4974.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | ¥45 | ¥44 | ¥78 | ¥68 |
| % Growth | 3.5% | -44.3% | 15.4% | – |
| Cost of Goods Sold | ¥19 | ¥17 | ¥33 | ¥18 |
| Gross Profit | ¥26 | ¥27 | ¥45 | ¥49 |
| % Margin | 57.9% | 61.9% | 57.3% | 72.7% |
| R&D Expenses | ¥7 | ¥8 | ¥9 | ¥6 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥17 | ¥16 | ¥16 | ¥14 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥0 | -¥0 | -¥0 |
| Operating Expenses | ¥24 | ¥24 | ¥24 | ¥20 |
| Operating Income | ¥2 | ¥3 | ¥21 | ¥29 |
| % Margin | 5% | 6.9% | 26.3% | 42.7% |
| Other Income/Exp. Net | -¥0 | -¥0 | ¥1 | -¥1 |
| Pre-Tax Income | ¥2 | ¥3 | ¥21 | ¥28 |
| Tax Expense | ¥1 | ¥1 | ¥5 | ¥8 |
| Net Income | ¥1 | ¥1 | ¥16 | ¥20 |
| % Margin | 2.3% | 3.4% | 20.5% | 29.3% |
| EPS | 8.65 | 12.29 | 132.97 | 164.84 |
| % Growth | -29.6% | -90.8% | -19.3% | – |
| EPS Diluted | 8.65 | 12.29 | 132.97 | 164.84 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥4 | ¥5 | ¥5 | ¥4 |
| EBITDA | ¥7 | ¥8 | ¥26 | ¥32 |
| % Margin | 14.4% | 18.2% | 33.3% | 46.8% |